Compare American Financial Group Inc (AFG) vs Davita Inc (DVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Financial Group Inc vs Davita Inc — how do they compare? American Financial Group Inc trades at $144.65 (market cap $11.97B), while Davita Inc trades at $179.02 (market cap $11.38B). The key difference: American Financial Group Inc and Davita Inc are close in size by market cap, and American Financial Group Inc pays a 2.44% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| AFG | DVA | |
|---|---|---|
Market Cap | $11.97B | $11.38B |
Sector | Financials | Health |
52-Week High | $148.71 | $240.96 |
52-Week Low | $124.18 | $103.87 |
Enterprise Value | $12.35B | $24.10B |
Dividend Yield | 2.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Financial Group Inc
American Financial Group Inc is a holding company that is engaged primarily in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. American also has annuity operations that are focused on sales of traditional fixed and fixed-indexed annuities in the education, bank, and individual markets. American's insurance operations are conducted through the Great American Insurance Group. The group writes business in all 50 of the United States, primarily through independent agents and brokers.
Read more on AFG →About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →
